ERNA
Ernexa Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.32
+0.01 ▲ +4.89%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$0.32
+0.00 -1.23%
| Index | - | P/E | - | EPS (ttm) | -4.75 | Insider Own | 29.7% | Shs Outstand | 0.03B | Perf Week | 13.72% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 98.89% | Shs Float | 0.02B | Perf Month | 7.28% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 1.93% | Short Float | 1.3% | Perf Quarter | -74.68% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | 0.15% | Short Ratio | 0.17 | Perf Half Y | -76.51% |
| Sales | 0.00B | P/B | 0.71 | EPS next 5Y | - | ROA | -264.07% | Short Interest | 0.25M | Perf YTD | -72.99% |
| Book/sh | 0.45 | P/C | 2.88 | EPS past 3/5Y | 61.36% 35.26% | ROE | -2264.31% | 52W High | -92.28% ($4.20) | Perf Year | -91.53% |
| Cash/sh | 0.11 | P/FCF | - | Sales past 3/5Y | - -50.61% | ROIC | -468.74% | 52W Low | 20.84% ($0.27) | Perf 3Y | -99.37% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 96.19% | Gross Margin | -26100% | Volatility(W/M) | 13.46% 14.4% | Perf 5Y | -99.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -99.83% | Oper. Margin | -992100% | ATR (14) | 0.06 | Perf 10Y | -99.99% |
| Dividend Ex-Date | - | Quick Ratio | 1.58 | EPS Q/Q | 99.8% | Profit Margin | - | RSI (14) | 34.85 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.58 | Sales Q/Q | -100% | SMA20 | 5.97% ($0.3) | Beta | 6.77 | Target Price | $9 |
| Payout | - | Debt/Eq | 0.15 | Earnings | - | SMA50 | -56.52% ($0.74) | Rel Volume | 2.37 | Prev Close | $0.31 |
| Employees | 6 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | - | SMA200 | -77.1% ($1.4) | Avg Volume(3M) | 1.46M | Price | $0.32 |
| IPO | 1991/8/29 | Option/Short | No/Yes | Trades | 1775 | Volume | 3,472,848 | Change | 4.89% |
뉴스 로딩 중...